StockData
Krystal Biotech, Inc. logo

Krystal Biotech, Inc. (KRYS) stock

KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 11/3062% above fair value
$315.34+16.79 (+5.62%)

Close on Nov 18, 2026Market cap $9.33BP/E 39.5Yield –

Krystal Biotech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Krystal Biotech's pe ratio was 38.7× on Nov 11, 2026, against 32.7× a year earlier. Over the last 3 years it ranged from 30.0× to 459.6×, with a median of 45.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202638.7×+1.7
2025Dec 31, 202537.0×−49.1
2024Dec 31, 202486.0×–

More Krystal Biotech figures

See a number that looks wrong?